Despite the immense commitment and dedication of those involved in finding treatments for CF, there remain huge challenges in bringing these benefits directly to those living with this chronic disease. Recent disappointments in the development of new CF medicines confirm the enormous difficulties faced and the need to strengthen our resolve for exciting alternatives, which offer very real and practical potential for the future.
I am delighted to be chairing this symposium and would like to invite you to register for the event (please click below). Understanding the daily complexities of managing life with CF is central to our theme and, to help with this, I would also ask you to take a couple of minutes to give your responses to 4 short questions in our online questionnaire. All the responses will be collated anonymously and I will be incorporating the results within my opening presentation during the symposium.
I very much hope you will join us on the day and take this chance to influence the content of the meeting.
See you in Hamburg!

Professor Stuart Elborn
Queen's University, Belfast.
President ECFS
| 14:30 | Refreshments (coffee/tea) | |
| 15:00 | Welcome and Introduction | Chairperson Prof Stuart Elborn Belfast, UK |
| 15:10 | What do CF patients really need? | Dr Louise Lannefors Lund, Sweden |
| 15:30 | The complexities of designing a new CF drug | Prof Felix Ratjen Toronto, Canada |
| 15:50 | Bronchitol: efficacy and tolerability from two large phase III studies | Prof Moira Aitken Seattle, US |
| 16:15 | Panel discussion | All |
| 16:25 | Summary | Chairperson Prof Stuart Elborn Belfast, UK |
| 16:30 | Close |
Date of preparation: May 2011 CF/EU/2011/029